126 related articles for article (PubMed ID: 38763390)
1. Challenges and prospects in treating macrolide-resistant Bordetella pertussis in Chinese paediatric practice.
Yang R; Xu H; Zhang Z; Liu Q; Wu X
J Infect; 2024 Jul; 89(1):106185. PubMed ID: 38763390
[No Abstract] [Full Text] [Related]
2. In vitro activity and clinical efficacy of macrolides, cefoperazone-sulbactam and piperacillin/piperacillin-tazobactam against Bordetella pertussis and the clinical manifestations in pertussis patients due to these isolates: A single-centre study in Zhejiang Province, China.
Hua CZ; Wang HJ; Zhang Z; Tao XF; Li JP; Mi YM; Tang LF; Chen ZM
J Glob Antimicrob Resist; 2019 Sep; 18():47-51. PubMed ID: 30710647
[TBL] [Abstract][Full Text] [Related]
3. High Prevalence of Macrolide-Resistant Bordetella pertussis and ptxP1 Genotype, Mainland China, 2014-2016.
Li L; Deng J; Ma X; Zhou K; Meng Q; Yuan L; Shi W; Wang Q; Li Y; Yao K
Emerg Infect Dis; 2019 Dec; 25(12):2205-2214. PubMed ID: 31742507
[TBL] [Abstract][Full Text] [Related]
4. Bordetella pertussis Infection in Infants and Young Children in Shanghai, China, 2016-2017: Clinical Features, Genotype Variations of Antigenic Genes and Macrolides Resistance.
Fu P; Wang C; Tian H; Kang Z; Zeng M
Pediatr Infect Dis J; 2019 Apr; 38(4):370-376. PubMed ID: 30882726
[TBL] [Abstract][Full Text] [Related]
5. The First Report of Macrolide-Resistant Bordetella pertussis Isolation in Japan.
Yamaguchi T; Kawasaki Y; Katsukawa C; Kawahara R; Kawatsu K
Jpn J Infect Dis; 2020 Sep; 73(5):361-362. PubMed ID: 32350216
[TBL] [Abstract][Full Text] [Related]
6. Effect of Macrolides and β-lactams on Clearance of Bordetella pertussis in the Nasopharynx in Children With Whooping Cough.
Mi YM; Hua CZ; Fang C; Liu JJ; Xie YP; Lin LN; Wang GL
Pediatr Infect Dis J; 2021 Feb; 40(2):87-90. PubMed ID: 33021592
[TBL] [Abstract][Full Text] [Related]
7. Appearance of macrolide-resistant Bordetella pertussis strains in China.
Wang Z; Li Y; Hou T; Liu X; Liu Y; Yu T; Chen Z; Gao Y; Li H; He Q
Antimicrob Agents Chemother; 2013 Oct; 57(10):5193-4. PubMed ID: 23877687
[No Abstract] [Full Text] [Related]
8. Antimicrobial susceptibility testing of Bordetella pertussis in Taiwan prompted by a case of pertussis in a paediatric patient.
Yao SM; Liaw GJ; Chen YY; Yen MH; Chen YH; Mu JJ; Chiang CS
J Med Microbiol; 2008 Dec; 57(Pt 12):1577-1580. PubMed ID: 19018032
[TBL] [Abstract][Full Text] [Related]
9. Where macrolide resistance is prevalent.
Li Y; Liu X; Zhang B; He Q; Wang Z
APMIS; 2015 Apr; 123(4):361-3. PubMed ID: 25703275
[No Abstract] [Full Text] [Related]
10. In vitro activity of macrolides against Bordetella pertussis strains isolated in 1968 and 30 years later in Poland.
Chodorowska M; Tyski S; Kuklińska D
Clin Microbiol Infect; 2000 Jan; 6(1):50-2. PubMed ID: 11168039
[No Abstract] [Full Text] [Related]
11. Surveillance of antimicrobial resistance in contemporary clinical isolates of Bordetella pertussis in Ontario, Canada.
Marchand-Austin A; Memari N; Patel SN; Tang P; Deeks SL; Jamieson FB; Crowcroft NS; Farrell DJ
Int J Antimicrob Agents; 2014 Jul; 44(1):82-4. PubMed ID: 24837412
[No Abstract] [Full Text] [Related]
12. Variation in Bordetella pertussis Susceptibility to Erythromycin and Virulence-Related Genotype Changes in China (1970-2014).
Yang Y; Yao K; Ma X; Shi W; Yuan L; Yang Y
PLoS One; 2015; 10(9):e0138941. PubMed ID: 26406905
[TBL] [Abstract][Full Text] [Related]
13. High-resolution melting analysis for the detection of two erythromycin-resistant Bordetella pertussis strains carried by healthy schoolchildren in China.
Zhang Q; Li M; Wang L; Xin T; He Q
Clin Microbiol Infect; 2013 Jun; 19(6):E260-2. PubMed ID: 23480481
[TBL] [Abstract][Full Text] [Related]
14. Modifying antibiotic treatment strategies in the face of pertussis surge associated to erythromycin resistance in China.
Shi W; Meng Q; Hu Y; Yao K
J Infect; 2024 Jun; 88(6):106174. PubMed ID: 38719109
[No Abstract] [Full Text] [Related]
15. Pertussis caused by an erythromycin-resistant strain of Bordetella pertussis.
Lewis K; Saubolle MA; Tenover FC; Rudinsky MF; Barbour SD; Cherry JD
Pediatr Infect Dis J; 1995 May; 14(5):388-91. PubMed ID: 7638015
[No Abstract] [Full Text] [Related]
16. High prevalence of erythromycin-resistant Bordetella pertussis in Xi'an, China.
Wang Z; Cui Z; Li Y; Hou T; Liu X; Xi Y; Liu Y; Li H; He Q
Clin Microbiol Infect; 2014 Nov; 20(11):O825-30. PubMed ID: 24816168
[TBL] [Abstract][Full Text] [Related]
17. Molecular Evolution and Increasing Macrolide Resistance of Bordetella pertussis, Shanghai, China, 2016-2022.
Fu P; Zhou J; Yang C; Nijiati Y; Zhou L; Yan G; Lu G; Zhai X; Wang C
Emerg Infect Dis; 2023 Jan; 30(1):29-38. PubMed ID: 38146984
[TBL] [Abstract][Full Text] [Related]
18. Analysis of antibiotic sensitivity and resistance genes of Bordetella pertussis in Chinese children.
Lin X; Zou J; Yao K; Li L; Zhong L
Medicine (Baltimore); 2021 Jan; 100(2):e24090. PubMed ID: 33466172
[TBL] [Abstract][Full Text] [Related]
19. Genomic epidemiology of erythromycin-resistant Bordetella pertussis in China.
Xu Z; Wang Z; Luan Y; Li Y; Liu X; Peng X; Octavia S; Payne M; Lan R
Emerg Microbes Infect; 2019; 8(1):461-470. PubMed ID: 30898080
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility testing of Finnish Bordetella pertussis isolates collected during 2006-2017.
Lönnqvist E; Barkoff AM; Mertsola J; He Q
J Glob Antimicrob Resist; 2018 Sep; 14():12-16. PubMed ID: 29486357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
